Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cancer Progress and Priorities: Uterine Cancer.

Literature DB >> 30181320

Cancer Progress and Priorities: Uterine Cancer.

Ashley S Felix¹, Louise A Brinton².

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Year: 2018 PMID： 30181320 PMCID： PMC6504985 DOI： 10.1158/1055-9965.EPI-18-0264

Source DB: PubMed Journal: Cancer Epidemiol Biomarkers Prev ISSN： 1055-9965 Impact factor: 4.254

× No keyword cloud information.

117 in total

1. Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas.

Authors: M E Sherman; S Sturgeon; L A Brinton; N Potischman; R J Kurman; M L Berman; R Mortel; L B Twiggs; R J Barrett; G D Wilbanks
Journal: Mod Pathol Date: 1997-10 Impact factor: 7.842

Review 2. Advances in endometrial cancer protein biomarkers for use in the clinic.

Authors: Elena Martinez-Garcia; Carlos Lopez-Gil; Irene Campoy; Julia Vallve; Eva Coll; Silvia Cabrera; Santiago Ramon Y Cajal; Xavier Matias-Guiu; Jan Van Oostrum; Jaume Reventos; Antonio Gil-Moreno; Eva Colas
Journal: Expert Rev Proteomics Date: 2017-11-30 Impact factor: 3.940

3. USA endometrial cancer projections to 2030: should we be concerned?

Authors: M Aamir Sheikh; Andrew D Althouse; Kyle E Freese; Sean Soisson; Robert P Edwards; Sharon Welburn; Paniti Sukumvanich; John Comerci; Joseph Kelley; Ronald E LaPorte; Faina Linkov
Journal: Future Oncol Date: 2014-12 Impact factor: 3.404

Review 4. Family history and risk of endometrial cancer: a systematic review and meta-analysis.

Authors: Aung Ko Win; Jeanette C Reece; Shae Ryan
Journal: Obstet Gynecol Date: 2015-01 Impact factor: 7.661

5. Endometriosis and risk of ovarian and endometrial cancers in a large prospective cohort of U.S. nurses.

Authors: Elizabeth M Poole; Wayne T Lin; Marina Kvaskoff; Immaculata De Vivo; Kathryn L Terry; Stacey A Missmer
Journal: Cancer Causes Control Date: 2017-03-15 Impact factor: 2.506

Review 6. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies.

Authors: Konstantinos K Tsilidis; John C Kasimis; David S Lopez; Evangelia E Ntzani; John P A Ioannidis
Journal: BMJ Date: 2015-01-02

7. Endometrial cancer risk prediction including serum-based biomarkers: results from the EPIC cohort.

Authors: Renée T Fortner; Anika Hüsing; Tilman Kühn; Meric Konar; Kim Overvad; Anne Tjønneland; Louise Hansen; Marie-Christine Boutron-Ruault; Gianluca Severi; Agnès Fournier; Heiner Boeing; Antonia Trichopoulou; Vasiliki Benetou; Philippos Orfanos; Giovanna Masala; Claudia Agnoli; Amalia Mattiello; Rosario Tumino; Carlotta Sacerdote; H B As Bueno-de-Mesquita; Petra H M Peeters; Elisabete Weiderpass; Inger T Gram; Oxana Gavrilyuk; J Ramón Quirós; José Maria Huerta; Eva Ardanaz; Nerea Larrañaga; Leila Lujan-Barroso; Emilio Sánchez-Cantalejo; Salma Tunå Butt; Signe Borgquist; Annika Idahl; Eva Lundin; Kay-Tee Khaw; Naomi E Allen; Sabina Rinaldi; Laure Dossus; Marc Gunter; Melissa A Merritt; Ioanna Tzoulaki; Elio Riboli; Rudolf Kaaks
Journal: Int J Cancer Date: 2017-03-15 Impact factor: 7.396

8. Cancer risks for MLH1 and MSH2 mutation carriers.

Authors: James G Dowty; Aung K Win; Daniel D Buchanan; Noralane M Lindor; Finlay A Macrae; Mark Clendenning; Yoland C Antill; Stephen N Thibodeau; Graham Casey; Steve Gallinger; Loic Le Marchand; Polly A Newcomb; Robert W Haile; Graeme P Young; Paul A James; Graham G Giles; Shanaka R Gunawardena; Barbara A Leggett; Michael Gattas; Alex Boussioutas; Dennis J Ahnen; John A Baron; Susan Parry; Jack Goldblatt; Joanne P Young; John L Hopper; Mark A Jenkins
Journal: Hum Mutat Date: 2013-03 Impact factor: 4.878

Review 9. Type I and II endometrial cancers: have they different risk factors?

Authors: Veronica Wendy Setiawan; Hannah P Yang; Malcolm C Pike; Susan E McCann; Herbert Yu; Yong-Bing Xiang; Alicja Wolk; Nicolas Wentzensen; Noel S Weiss; Penelope M Webb; Piet A van den Brandt; Koen van de Vijver; Pamela J Thompson; Brian L Strom; Amanda B Spurdle; Robert A Soslow; Xiao-ou Shu; Catherine Schairer; Carlotta Sacerdote; Thomas E Rohan; Kim Robien; Harvey A Risch; Fulvio Ricceri; Timothy R Rebbeck; Radhai Rastogi; Jennifer Prescott; Silvia Polidoro; Yikyung Park; Sara H Olson; Kirsten B Moysich; Anthony B Miller; Marjorie L McCullough; Rayna K Matsuno; Anthony M Magliocco; Galina Lurie; Lingeng Lu; Jolanta Lissowska; Xiaolin Liang; James V Lacey; Laurence N Kolonel; Brian E Henderson; Susan E Hankinson; Niclas Håkansson; Marc T Goodman; Mia M Gaudet; Montserrat Garcia-Closas; Christine M Friedenreich; Jo L Freudenheim; Jennifer Doherty; Immaculata De Vivo; Kerry S Courneya; Linda S Cook; Chu Chen; James R Cerhan; Hui Cai; Louise A Brinton; Leslie Bernstein; Kristin E Anderson; Hoda Anton-Culver; Leo J Schouten; Pamela L Horn-Ross
Journal: J Clin Oncol Date: 2013-06-03 Impact factor: 44.544

10. Current cigarette smoking among adults--United States, 2005-2013.

Authors: Ahmed Jamal; Israel T Agaku; Erin O'Connor; Brian A King; John B Kenemer; Linda Neff
Journal: MMWR Morb Mortal Wkly Rep Date: 2014-11-28 Impact factor: 17.586

11 in total

1. Krüppel-like factor 5 is upregulated and induces cell proliferation in endometrial cancer.

Authors: Tetsuya Moritake; Junya Kojima; Kaiyu Kubota; Fumitoshi Terauchi; Keiichi Isaka; Hirotaka Nishi
Journal: Oncol Lett Date: 2021-04-21 Impact factor: 2.967

2. Physical Activity From Adolescence Through Midlife and Associations With Body Mass Index and Endometrial Cancer Risk.

Authors: Pedro F Saint-Maurice; Joshua N Sampson; Kara A Michels; Steven C Moore; Erikka Loftfield; Kathleen McClain; Michael B Cook; Britton Trabert; Charles E Matthews
Journal: JNCI Cancer Spectr Date: 2021-07-16

3. Hysterectomy-Corrected Uterine Corpus Cancer Incidence Trends and Differences in Relative Survival Reveal Racial Disparities and Rising Rates of Nonendometrioid Cancers.

Authors: Megan A Clarke; Susan S Devesa; Summer V Harvey; Nicolas Wentzensen
Journal: J Clin Oncol Date: 2019-05-22 Impact factor: 44.544

Cancer Progress and Priorities: Uterine Cancer.

1. Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas.

Review 2. Advances in endometrial cancer protein biomarkers for use in the clinic.

3. USA endometrial cancer projections to 2030: should we be concerned?

Review 4. Family history and risk of endometrial cancer: a systematic review and meta-analysis.

5. Endometriosis and risk of ovarian and endometrial cancers in a large prospective cohort of U.S. nurses.

Review 6. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies.

7. Endometrial cancer risk prediction including serum-based biomarkers: results from the EPIC cohort.

8. Cancer risks for MLH1 and MSH2 mutation carriers.

Review 9. Type I and II endometrial cancers: have they different risk factors?

10. Current cigarette smoking among adults--United States, 2005-2013.

1. Krüppel-like factor 5 is upregulated and induces cell proliferation in endometrial cancer.

2. Physical Activity From Adolescence Through Midlife and Associations With Body Mass Index and Endometrial Cancer Risk.

3. Hysterectomy-Corrected Uterine Corpus Cancer Incidence Trends and Differences in Relative Survival Reveal Racial Disparities and Rising Rates of Nonendometrioid Cancers.

4. Palmitate Enhances the Efficacy of Cisplatin and Doxorubicin against Human Endometrial Carcinoma Cells.

Review 5. Sentinel Lymph Node Mapping in High-Grade Endometrial Cancer.

6. Proteomic Analysis of Endometrial Cancer Tissues from Patients with Type 2 Diabetes Mellitus.

7. Characterizing the extracellular matrix transcriptome of cervical, endometrial, and uterine cancers.

8. Tissue-Based Proteomic Profiling in Patients with Hyperplasia and Endometrial Cancer.

9. Factors associated with endometrial cancer and hyperplasia among middle-aged and older Hispanics.

10. Non-invasive detection of endometrial cancer by DNA methylation analysis in urine.